---
title: "INDiGO: Fast Tracked Development of a BCS Class IV Drug"
description: "https://news.evotec.com/indigo-fast-tracked-development-despite-being-a-bcs-class-iv-drug
Read our our INDiGO case study on fast tracked development of a BCS class IV drug. Contact Evotec to learn more!"
image: https://news.cyprotex.com/hubfs/Sciencepool/Sciencepool%20images/Inhouse%20images/VH-shutterstock_1334759021-1220527450-case-study-01-science-pool.jpg
---

[![Cyprotex | The Leading ADME-Tox Specialist](https://news.cyprotex.com/hs-fs/hubfs/cyprotex%20logo.png?width=224&height=62&name=cyprotex%20logo.png "Cyprotex | The Leading ADME-Tox Specialist")](https://www.cyprotex.com/)

# Science Pool

# INDiGO: Fast Tracked Development of a BCS Class IV Drug

Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 3, 2021 4:47:11 PM

 Tags: [Case Studies](https://news.cyprotex.com/sciencepool/tag/case-studies), [Formulation & CMC](https://news.cyprotex.com/sciencepool/tag/formulation-cmc), [IND Enabling Studies/Preclinical Development](https://news.cyprotex.com/sciencepool/tag/ind-enabling-studies-preclinical-development)